Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus

Mohammad-Reza Movahed1, Mehrtash Hashemzadeh, Mazen Jamal

  • 1Department of Medicine, Section of Cardiology, University of Arizona Sarver Heart Center, 1501 North Campbell Avenue, Tucson, AZ 85724-5037, USA. rmova@aol.com

Heart and Vessels
|July 27, 2007
PubMed

Insights

Diabetes mellitus (DM) significantly increases the risk of ventricular fibrillation, independent of heart conditions. This finding in diabetic patients may explain their higher risk of sudden cardiac death.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus (DM) is a known risk factor for cardiovascular disease.
  • Patients with DM have a higher incidence of ventricular arrhythmias, often attributed to coronary artery disease (CAD) or congestive heart failure (CHF).

Purpose of the Study:

  • To investigate whether DM independently contributes to ventricular arrhythmias, irrespective of CAD or CHF.
  • To evaluate the association between DM and ventricular fibrillation (VF).

Main Methods:

  • Utilized a large database from Veterans Health Administration Hospitals.
  • Stratified patients into two groups: those with DM (n=293,124) and a control group with hypertension but no DM (n=552,623).
  • Analyzed the occurrence of ventricular fibrillation using ICD-9 codes and performed uni- and multivariant analyses, adjusting for comorbid conditions.

Main Results:

  • Ventricular fibrillation was observed in 0.2% of patients with DM compared to 0.1% in the control group.
  • Multivariate analysis confirmed that DM is independently associated with ventricular fibrillation (Odds Ratio: 1.7; 95% CI: 1.5-1.9; P < 0.000).

Conclusions:

  • Diabetes mellitus is associated with a significantly higher prevalence of ventricular fibrillation, independent of CAD or CHF.
  • This independent association may contribute to the elevated risk of sudden cardiac death observed in patients with DM.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...